Chief Executive Office
Kylie Sproston is CEO of Bellberry, a not-for-profit organisation providing streamlined scientific and ethical review of Human Research projects across Australia. As a not-for-profit organisation, Bellberry invests all proceeds back into the research community through fellowships, Research Infrastructure and Project Grant funding.
A Chartered Engineer, Kylie has expertise across the full pharmaceutical product lifecycle, and has held key positions in both technical and management disciplines in the global Pharmaceutical and Biotech industries. Kylie previously led and managed the Australasian operations of the global group BTG PLC (a specialist healthcare company based in London, UK), as General Manager and Company Director. Prior to that, Kylie undertook a number of roles within various functions in the Global company AstraZeneca.
Kylie received an MEng (Hons) in Mechanical Engineering from Loughborough University (UK) and an MSc in Pharmaceutical Engineering Advanced Training from University of Manchester (UK). She is a Graduate of the AICD Company Directors Course.
Patient Centric Approach to Enhance Conduct of Research – Ethical Consideration
< Back to Speakers' Information
Subcribe to our mailing list to get the latest education updates.